SCHEMBL6174217

SCHEMBL6174217

CC(c1ccnc(NNC(=O)c2ccccc2)c1)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.38
LMNA P02545 1/20 0.34
GAA P10253 3/20 0.33
ALDH1A1 P00352 2/20 0.32
TRPV3 Q8NET8 2/20 0.31
HTR2A P28223 1/20 0.31
TSPO P30536 1/20 0.31
GPR183 P32249 1/20 0.31
APLNR P35414 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
CBLB Q13191 1/20 0.31
PTGS2 P35354 1/20 0.31
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
USP2 O75604 1/20 0.30
RECQL P46063 1/20 0.30
KMT2A Q03164 1/20 0.30
ATM Q13315 1/20 0.30
NPC1 O15118 2/20 0.30
RAB9A P51151 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6177220 0.87 LMNA (0.40) LMNA
SCHEMBL6177584 0.87 IGF1R (0.38) IGF1RLMNA
SCHEMBL6174110 0.85 NPC1 (0.39) IGF1RALDH1A1CBLBNPC1RAB9A
SCHEMBL6172184 0.85 NPC1 (0.39) IGF1RLMNAGAAALDH1A1CBLB
SCHEMBL6175133 0.84 GRM5 (0.43) ALDH1A1CBLBNPC1RAB9A
SCHEMBL6173893 0.84 LMNA (0.39) IGF1RLMNAGAAALDH1A1HTR2A
SCHEMBL6174034 0.83 CBLB (0.36) IGF1RALDH1A1HTR2ATSPOGPR183
SCHEMBL6176337 0.83 NPC1 (0.39) LMNAGAAALDH1A1CBLBKDM4E
SCHEMBL6173894 0.83 IGF1R (0.37) IGF1RLMNATRPV3
SCHEMBL6174834 0.83 GRM1 (0.39) IGF1RLMNAHTR2ATSPOGPR183

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed